Open AccessPatient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
Author(s) -
Karen E. Hoffman,
David F. Penson,
Zhiguo Zhao,
LiChing Huang,
Ralph Conwill,
Aaron A. Laviana,
Daniel Joyce,
Amy N. Luckenbaugh,
Michael Goodman,
Ann S. Hamilton,
XiaoCheng Wu,
Lisa E. Paddock,
Antoinette M. Stroup,
Matthew R. Cooperberg,
Mia Hashibe,
Brock B. OʼNeil,
Sherrie H. Kaplan,
Sheldon Greenfield,
Tatsuki Koyama,
Daniel A. Barocas
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2019.20675
Subject(s) - medicine , prostate cancer , brachytherapy , prostatectomy , androgen deprivation therapy , external beam radiotherapy , urology , radiation therapy , population , prostate specific antigen , sexual function , oncology , cancer , gynecology , environmental health
Understanding adverse effects of contemporary treatment approaches for men with favorable-risk and unfavorable-risk localized prostate cancer could inform treatment selection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom